
Ep 53: Cradle CEO Stef van Grieken on the State of AI x Bio and Selling SaaS to Pharma
Vital Signs with Jacob Effron and Nikhil Krishnan
Intro
This chapter explores the integration of artificial intelligence within the biotechnology sector, specifically in creating biologics and small molecules. It discusses progress made in AI applications for hit identification and lead optimization, alongside the need for further validation in research and clinical trials.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.